Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial

• Main Authors: Jianguo Lin (Author), Qingqing Wang (Author), Dongsheng Zhong (Author), Jinju Zhang (Author), Tianhui Yuan (Author), Hui Wu (Author), Bin Li (Author), Shuangdi Li (Author), Xiaoliu Xie (Author), Dongqing An (Author), Yue Deng (Author), Shaoxiang Xian (Author), Xingjiang Xiong (Author), Kuiwu Yao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Hypertension, a major cardiovascular risk factor, severely impacts patients' quality of life. Qiangli Dingxuan tablet (QDT) is a formally approved Chinese patent medicine, which has been widely used as an adjunctive treatment for hypertension. This study aimed to investigate the ant...